Answers are grounded in this paper and cite their sources.
The anterior cingulate gyrus (ACG) is a forebrain structure located in the mesial frontal lobe comprised of anterior cingulate cortex (ACC) and the associated portion of the cingulum comprising similar cytoarchitectural tissue defined as Brodmann's Areas 24, 32, and 35. 1,2 Functional MRI (fMRI) studies exploring neuroanatomical correlates of pain show Blood Oxygen Level-Dependent (BOLD) elevations in the ACC in response to painful stimuli and decreased BOLD activity with nonpainful stimuli. 3,4 Animal models demonstrate that excitation of the ACC increases aversive behavior in response to painful stimuli. [5][6][7][8] Adult patients with obsessive compulsive disorder (OCD), 9,10 major depressive disorder (MDD), 11 and chronic pain disorders such as back pain, migraine, and craniomandibular disorders 12 consistently reveal abnormal resting-state activity in the ACC. Recently, ACG surgery has been attempted to address intractable pain-related suffering in adults, via either laser interstitial thermal therapy (LITT) and neuromodulation via deep brain stimulation (DBS). The neurosurgical evidence suggests that ablative or neuromodulatory ACG surgery can significantly improve pain and quality of life in adult patients 13 with chronic and refractory neuropathic pain, 14,15 cancer-related pain, 16 non-cancer pain, 17 or severe depression. 15,18 As a whole, the current neuroscientific literature suggests the ACC plays a central role in the negative, affective component of pain, and that surgical targeting of the ACG can significantly reduce pain-related suffering.While data primarily supports ACG surgery in adults, children with cerebral palsy (CP), 19-21 chronic regional pain syndrome (CRPS), 22 advanced cancer, 23,24 and treatment-resistant major depressive disorder 25 also experience chronic, medically intractable pain. Additionally, ethnographic research shows that in pediatric critical care contexts, "suffering" --which is notoriously difficult to define or quantify 26 -is invoked three times more often to justify withdrawal of care than to sustain a child's life. 27 This research suggests intractable pediatric pain and suffering are principal factors in determining survival outcomes for critically ill children and remain inadequately addressed, underscoring an urgent duty to improve the treatment of intractable pain and suffering in pediatrics. This literature raises the following question: can we -and should we -perform ACG surgery to target and treat refractory pain or pain-related suffering in children?Various frameworks help determine the clinical and ethical justifiability of pediatric ACG (Table 1). Davidson et al. have proposed that the ethical justifiability of any innovative form of pediatric DBS surgery requires five specific expectations be met: (1) the protection of the child's best interest, (2) consideration of developmental context, (3) mitigation of "relative" known and unknown risks, (4) avoidance of overreliance on the adult literature, and (5) communication of trial results and collaboration with other practitioners. 28 Similarly, Lipsman et al. proposed the ethical permissibility of any form of pediatric psychosurgery requires meeting seven criteria: (a) proper discussion of patient selection, (b) evidence-based rationale surpassing a consensus-driven threshold for surgical intervention, (c) demonstration of the disease burden, (d) transparent informed consent, (e) multidisciplinary review of individual cases, (f) proper oversight of all aspects of the research, and (g) routine scheduled evaluations focused ensuring ethical trial design. In tandem, these frameworks suggest pediatric ACG surgery is ethically justifiable if it, firstly, serves the best interest of the child (1). Given ACG surgery's elevated degree of invasiveness and experimental nature, neurosurgically addressing pain-related suffering would only serve the pediatric patient's best interest in the following clinical scenarios: if medical analgesic therapy is ineffective or insufficient, compromises the child's conscious state via oversedation, or produces intolerable side effects significantly impairing quality of life such as respiratory depression, hyperalgesia, urinary retention, nausea, vomiting, pruritis, or withdrawal; or if other interventional/surgical pain interventions have also failed or are unsuitable. These scenarios may arise in the setting of intractable chronic pain syndromes such as CRPS, end-stage sickle cell disease, or peripheral nerve injury, refractory psychiatric disease such as OCD, or terminal cancer. Though instances of massive analgesic therapy for these diseases are rare, they do occur and are ethically controversial given the nonzero probability of oversedation or precipitate pharmacological dependence. As has been proposed regarding cordotomies in adults with terminal cancer, 30 neurosurgery for medically intractable pain is clinically and ethically justifiable as it addresses the patient's primary concern of pain, often greater than the fear of death, 31 and minimizes use of opioid therapy. While children may not fear pain as much as adults, minimizing pain-related suffering when safe and possible is morally uncontroversial. Regarding patient selection (a), only pediatric patients with convincing signs of pain-related suffering, whose medical or procedural pain regimen is either ineffective, undesirably sedating, or significantly impairing, should be considered, given the highly experimental and invasive nature of the procedure. Finally, whether the patient is chronically versus terminally ill may be of ethical import. The severity of the patient's pain burden carries great weight in light of the "rule of rescue" described in the bioethical literature, 32 and patients with non-cancer pain may by definition suffer for longer. For that very reason, however, the current lack of procedure-specific efficacy and side-effect data calls for a tiered roll-out of this experimental surgery, described below.Developmentally (2), research demonstrates the sulcal structure of the ACG is relatively stable from early infancy into adulthood, suggesting robust neuroanatomic and functional development before birth or shortly thereafter. 33 However, sulcal stability alone does not ensure anatomical landmarks are similar in pediatric patients compared to adults. We propose that the ACG target be defined on a case-by-case basis using patient-specific, intraoperative MRI as opposed to relying on adult anatomical landmarks.Similarly, given the experimental nature of this surgery, we propose that initial candidacy be limited to adolescent patients with mature, MRI-confirmable cingulate anatomy.Post-operative cognitive functioning also warrants particular caution. Though ablating or modulating the ACG may lead to a reduced ability to distinguish favorable versus unfavorable experiences after surgery, protecting this function may pale in comparison to the immediate imperative to address the child's intractable suffering, especially at the end of life. Though adult studies have not shown significant cognitive post-operative deficits, such lack of positive results may reflect developed learned decisionmaking skills; as such, children may be at greater risk. On the other hand, children are more neuroplastic than adult counterparts, supporting surgical intervention in hopes of neuroplastic compensation. To this caution, we propose a "smallest effective lesion" goal and explicit disclosure of this possibility during the informed consent process.Clinically, the evidence (b) for pediatric ACG surgery currently rests on three pediatric cingulotomy case reports [34][35][36] and the favorable safety outcomes of a long history of DBS surgery on pediatric patients. 37,38 The literature also contains Level III efficacy and safety outcomes for pediatric stereotactic ablation via laser interstitial thermal therapy (LITT) or radiofrequency ablation (RF) of various neuroanatomical targets, 15,[39][40][41][42][43] supporting the clinical feasibility of pediatric ACG surgery. On the other hand, in adults, the efficacy of ACG surgery is also limited to case report data, [13][14][15][16][17][18] reducing the likelihood of overreliance on adult literature (4) but reinforcing the surgery's experimental nature. Infection, blood loss, adverse neurological side effects, and caregiver conflict in surgical decision-making are all risks requiring effective mitigation strategies (3). Infection can be mitigated by carefully selecting intervention type per patient needs. DBS leads to hardware-dependent infection (approximately 5%), a risk that is higher than with LITT or RF, 44 though LITT or RF may produce higher rates of infection than high intensity focused ultrasound (HIFU), another non-invasive, stereotactic procedural modality. Long-term adult data on anterior cingulate DBS also show that the risk of seizure induction is not null (approximately 8-18%), 14 and incident seizures may be irreversible.As such, we propose ablative cingulotomy (via LITT, RF, or HIFU, depending on the clinical and demographic picture) as the primary candidate procedure, and DBS only as a theoretical alternative. While neurological side effects of ablation are not perfectly predictable given ACG surgery's innovative nature, they may be mitigated by ensuring optimal stereotactic precision, utilizing intraoperative neuromonitoring, and avoiding other neuroanatomical structures during surgery. Blood loss can also be mitigated by setting surgical time-goals and optimizing pre-operative hemoglobin levels.Of all recommended justifiability criteria, demonstration of disease burden (c) is perhaps the hardest to meet in this patient population, as pain and suffering are notoriously difficult to quantify in any patient population. Pain is best measured in children via age and developmentally appropriate self-reported scales, such as the Visual Analog Scale (VAS) for verbal children, and observational scales for pre-or non-verbal patients such as the Faces, Legs, Activity, Cry, Consolability (FLACC) scale, but is still significantly challenging. Suffering is even harder to measure, as it is operationally challenging, requires subjective self-reporting, and is influenced by cultural values. 45 Shared decision-making with parents, along with child assent, may thus play a larger role in the justifiability of this procedure, as it may serve as both consent and third-party confirmation of sufficient disease burden. In this manner, while pain and suffering may be difficult to quantitatively measure in non-verbal and verbal pediatric patients, their empirical elusiveness does not negate neither their existence nor the duty to treat them, especially given their centrality in determining survival outcomes at the end of life and their effect on the well-being of both patient and family.Given the notable lack of procedure-specific efficacy data, we propose a tiered roll-out of this investigational surgery. Since the risk of operating on patients with longer expected survival is ethically suspect in an invasive, experimental surgery of this kind, patients with limited life-expectancy indications should be considered first. After robust pilot outcomes data is established and favorable, patients with intractable non-terminal pain ought to be considered Finally, the communication of trial results (5), transparent informed consent (d), multidisciplinary review (e), proper oversight (f), and routine scheduled evaluation of ethical design (g) are all reasonably achievable and expected by following the clinical guidelines for any surgical trial set by the Idea, Development, Exploration, Assessment, and Long-term Follow-up (IDEAL) Framework and Recommendations. 46 We also propose three other safeguards: (a) detailed pre-and post-operative neuropsychological assessment where appropriate; (b) restriction of these procedures to academic centers operating under strict governance frameworks; and (c) methodical registry of all cases to generate evidence on the efficacy and side effects of this treatment. IRBs or other institutional regulatory bodies may serve as final arbiters of the justifiability of each surgical case per the aforementioned criteria, especially during the surgery's investigational stage.As such, we propose that pediatric ACG surgery is clinically and ethically justifiable if the outlined criteria are met (Table 2). Anterior cingulate surgery produces favorable outcomes in adults; children also suffer from intractable pain-related suffering. Pediatric ACG surgery is clinically and ethically justifiable in the medically appropriate circumstances. Ablative ACG surgery should be considered, within a tiered roll-out beginning with palliative indications, for carefully selected patients to treat pain-related suffering, with the goal of improving quality of life and preventing premature withdrawal of care.
No takes yet. Share an insight, caveat, or question.
Townsend et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: